DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q1 2024 13F-HR Holdings
Net value change ($000)
+332,431
(6.1%)
New positions
224
Sold out positions
77
Turnover %
10.5%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| LRMR | 84,068 | 109.1% |
| Fusion Pharmaceuticals Inc. | 74,955 | 121.9% |
| AHCO | 53,397 | 53.8% |
| BNTX | 52,543 | NEW |
| SPRY | 52,509 | 86.5% |
| VTRS | 40,335 | 18.7% |
| CNC | 39,053 | 26.4% |
| KURA | 39,032 | 51.1% |
| OSCR | 36,470 | 35.4% |
| KYTX | 36,324 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| RayzeBio, Inc. | -62,551 | -100.0% |
| BAX | -52,265 | -99.5% |
| SpringWorks Therapeutics, Inc. | -31,172 | -33.0% |
| CABA | -24,102 | -52.9% |
| NBIX | -22,849 | -19.3% |
| PODD | -19,958 | -51.4% |
| Deciphera Pharmaceuticals, Inc. | -12,709 | -13.6% |
| DCGO | -9,118 | -30.7% |
| QDEL | -8,965 | -35.0% |
| REPL | -8,713 | -57.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|